Department of Medical Sciences, McMaster University, Hamilton, Ontario, Canada.
Section of Critical Care Medicine, Department of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
Am J Physiol Regul Integr Comp Physiol. 2023 May 1;324(5):R613-R624. doi: 10.1152/ajpregu.00003.2023. Epub 2023 Mar 6.
Sepsis, a medical emergency, is the overwhelming host response to infection leading to organ failure. The pathophysiology of this heterogeneous disease includes an inflammatory response that stimulates a complex interaction between endothelial and complements with associated coagulation abnormalities. Despite a more comprehensive understanding of sepsis pathophysiology, there exists a translational gap to improve sepsis diagnosis clinically. Many of the proposed biomarkers to diagnose sepsis lack sufficient specificity and sensitivity to be used in routine clinical practice. There has also been a lack of progress in diagnostic tools due to the focus on the inflammatory pathway. Inflammation and coagulation are known to be linked to the innate immune response. Early immunothrombotic changes could result in the early switch from infection to sepsis and aid in sepsis diagnosis. This review integrates both preclinical and clinical studies that highlight sepsis pathophysiology providing a framework for how the development of immunothrombosis could be used as a starting point to investigate biomarkers for early sepsis diagnosis.
脓毒症是一种医学急症,是宿主对感染的过度反应,可导致器官衰竭。这种异质性疾病的病理生理学包括炎症反应,炎症反应刺激内皮细胞和补体之间的复杂相互作用,并伴有相关的凝血异常。尽管对脓毒症的病理生理学有了更全面的了解,但在改善脓毒症的临床诊断方面仍存在转化差距。许多用于诊断脓毒症的拟议生物标志物缺乏足够的特异性和敏感性,无法在常规临床实践中使用。由于研究重点主要放在炎症途径上,因此诊断工具方面也没有取得进展。炎症和凝血被认为与先天免疫反应有关。早期的免疫血栓形成变化可能导致感染向脓毒症的早期转变,并有助于脓毒症的诊断。这篇综述整合了临床前和临床研究,强调了脓毒症的病理生理学,为免疫血栓形成的发展如何可以作为研究早期脓毒症诊断生物标志物的起点提供了一个框架。